Tarui disease (GSD type VII): management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Tarui disease (GSD type VII): management. Haemolytic anaemia, Reticulocytosis, Hyperuricemia. Fully referenced neurology checklist.
Blood tests
- Haemolytic anaemia
- Reticulocytosis
- Hyperuricemia
- Creatinine kinase (CK): this is elevated
- PFK activity: this is reduced
- Serum bilirubin: this is elevated
Other tests
Locked: subscribe to see this section.
Muscle biopsy
Locked: subscribe to see this section.
Physical management
Locked: subscribe to see this section.
Other management issues
Locked: subscribe to see this section.
References
- DiMauro S, Spiegel R. Progress and problems in muscle glycogenoses. Acta Myol 2011; 30:96-102.
- Musumeci O, Bruno C, Mongini T, et al. Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). Neuromuscul Disord 2012; 22:325-330.
- Toscano A, Musumeci O. Tarui disease and distal glycogenoses: clinical and genetic update. Acta Myol 2007; 26:105-107.
- Lucia A, Martinuzzi A, Nogales-Gadea Get al. Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group. Neuromuscul Disord 2021; 31:1296-1310.
